Better Therapeutics to Participate in Three Upcoming Investor Conferences
September 07 2022 - 7:30AM
Business Wire
Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital
therapeutics (PDT) company developing nutritional cognitive
behavioral therapy (nCBT) to address the root causes of
cardiometabolic diseases, today announced that Frank Karbe, Chief
Executive Officer, along with other members of the company’s
management team, will participate in three upcoming investor
conferences in September 2022.
- H.C. Wainwright 24th Annual Global Investment Conference being
held in New York on September 13, 2022.
- Lake Street 6th Annual Best Ideas Growth (BIG6) Conference
being held in New York on September 14, 2022.
- LifeSci Partners HealthTech Symposium being held virtually on
September 20, 2022. Better Therapeutics will participate in a
fireside chat at 2:45 p.m. ET / 11:45 a.m. PT.
Better Therapeutics management will be available for one-on-one
meetings during the conferences. The webcast and replay of the
LifeSci Partners HealthTech Symposium fireside chat will be
available on the Presentations and Events page of the Better
Therapeutics website at www.bettertx.com for approximately 30 days
after the event.
About Better Therapeutics
Better Therapeutics is a prescription digital therapeutics (PDT)
company developing a novel form of cognitive behavioral therapy
(CBT) to address the root causes of cardiometabolic diseases. The
company has developed a proprietary platform for the development of
FDA-regulated, software-based solutions for type 2 diabetes, heart
disease and other conditions. The CBT delivered by Better
Therapeutics’ PDT is designed to enable changes in neural pathways
of the brain so lasting changes in behavior become possible.
Addressing the underlying causes of these diseases has the
potential to dramatically improve patient health while lowering
healthcare costs. Better Therapeutics’ clinically validated mobile
applications, if authorized for marketing, are intended to be
prescribed by physicians and reimbursed like traditional
medicines.
For more information visit: bettertx.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220907005541/en/
Investor Relations: Mark Heinen IR@bettertx.com
Media: Ryan McKenna at Real Chemistry
rmckenna@realchemistry.com
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Apr 2023 to Apr 2024